The Chronos boss fight is, by far, the most difficult challenge you will face in Hades 2. Once you finally deplete his health bar in Tartarus and are no doubt starting to rejoice, Chronos pulls yet ...
(UroToday.com) The 2023 ESMO annual meeting included a session on prostate cancer, featuring a presentation by Dr. William Kelly discussing interim results from a phase 1 study of AMG 509 (xaluritamig ...
(UroToday.com) The 2024 American Society of Clinical Oncology (ASCO) annual meeting featured a session on prostate cancer, and a presentation by Dr. Daniel Petrylak discussing initial results of a ...
The change in ownership is noted in a single sentence on the “About” page on Throtle’s website: “Throtle Inc. is a wholly owned subsidiary of IQVIA Inc., operating as an independent unit within IQVIA ...
22 Division of Rheumatology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand 23 Division of Rheumatology, Department of Internal Medicine, Chonnam ...
New Delhi [India], November 7 (ANI): Prime Minister Narendra Modi sounding the poll bugle in Bihar's Aurangabad on Friday, took a sarcastic jab at the Opposition's 'rift-ridden' Mahagathbandhan ...
Construction is about to begin on the next part of the Kickapoo Rail Trail, which will connect the existing trail in St. Joesph to Ogden. NFL star Amon-Ra St. Brown's Donald Trump gesture goes viral ...
CastleVax, a clinical-stage biotechnology company developing intranasal vaccines using its attenuated Newcastle Disease Virus (NDV)-based vaccine platform, announced today that the first participant ...
Hosted on MSN
“Khesari, Anant, Tej Pratap, Maithili to Tejashwi: Bihar’s 10 most explosive Phase 1 contests
The first phase of the 2025 Bihar Legislative Assembly election on November 6 will set the early momentum, and the spotlight is on 10 high-stakes seats. From Tejashwi Yadav defending his Raghopur ...
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of ...
(MENAFN- GlobeNewsWire - Nasdaq) Dubai, UAE, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM) continues to advance steadily through its development roadmap, completing its Phase 2 milestones as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback